New food raw materials: Lactobacillus strain, dihydroquercetin, monk’s rhubarb up for consideration in China

By Tingmin Koe

- Last updated on GMT

Monk’s rhubarb, also known as rumex patientia L.  ©Getty Images
Monk’s rhubarb, also known as rumex patientia L. ©Getty Images

Related tags China Raw material regulations

China is seeking public comments on the use of the lactobacillus rhamnosus MP108 and two other raw materials for use in food.

The other two raw materials are monk’s rhubarb (rumex patientia L.​) and dihydroquercetin (DHQ), according to the announcement​ from the China National Center for Food Safety Risk Assessment (CFSA).

These raw materials have been assessed for its safety. After going through the public consultation, they may be officially added into the list of permitted food raw materials.

The probiotic lactobacillus rhamnosus ​MP108 is isolated from the faeces of healthy infants.

The CFSA is proposing the use of the strain in infant foods.

Overseas, the strain is already added into infant foods and such products are also sold in Australia, said the CFSA.

In Taiwan, it has been sold as a probiotic supplement branded ComProbi by Chuang Yi Biotech’s (CY Biotech).

Existing research shows that it could reduce the symptoms of atopic dermatitis​ in children.

On the other hand, dihydroquercetin is proposed for use in beverages at 20mg/L, fermented milk at 20mg/kg, and cocoa products at 70mg/kg.

However, infants, children below 14 years old, pregnant women, and breastfeeding mothers are not advised to consume the ingredient. 

Dihydroquercetin is commonly found in onion, milk thistle, and the French maritime pine bark. Some research studies have suggested that it could be used against skin aging.

The last raw material on the list is monk’s rhubarb. Its recommended daily consumption is 50g when consumed in fresh products. Similar to dihydroquercetin, infants, pregnant and breastfeeding women are not advised to take the ingredient.

The public consultation process will close on Dec 12.

This is part of the authority’s efforts to expand the number of raw materials that could be used in foods.

Aside from raw food materials, China is also expanding the number of permitted food additives and food contact materials as part of its “Three New” food policy (三新食品).

Although the above list of raw materials has shown to produce health benefits, firms are not able to make health claims if they are used in general foods.

To make health claims, these raw materials must be incorporated into health foods which will require firms to go through the health foods application route. 


The authorities decide the types of raw materials that could be used in foods based on applications from the industry. It will call for public comments after the raw materials have passed safety tests.

So far, most of the raw materials that have been put up for public consultation are botanicals, followed by new probiotic strains, Hangzhou-based regulatory consultancy firm CIRS has observed.  

Another trend is that the authorities are conducting more of such public consultations and are actively encouraging the industry to take part in expanding the list of raw materials that could be used in foods, Cathy Yu, GM at the food business division told NutraIngredients-Asia.

“The authorities will also more likely approve raw materials that have been approved overseas and/or used in foods in overseas,”​ she said.

An example of new raw materials that have been approved for use in foods was Lallemand Health Solutions’ three probiotic strains.

Earlier this year, three of its strains, lactobacillus helveticus ​R0052, Bifidobacterium infantis ​R0033, and Bifidobacterium bifidum ​R0071 were added into the food raw material list. 

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Gencor Pacific Limited

Gencor Pacific Limited

Content provided by Gencor | 05-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

Explore the capabilities with PlexoZome®

Explore the capabilities with PlexoZome®

Content provided by Gencor | 11-Aug-2023 | White Paper

Explore the capabilities PlexoZome® offers for your formulation.

Pharmako Biotechnologies, Gencor’s sister company, developed PlexoZome®,...

Related suppliers

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast